Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Asia Pacific Poultry Diagnostic Market Forecast to 2030 - Regional Analysis -By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)
... Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) The Asia Pacific poultry diagnostic market is expected to grow from US$ 127.46 million in 2022 to US$ 289.42 million by 2030. It is estimated to grow at ... Read More
-
Conjugate Vaccine Market by Type (Monovalent, Multivalent), Indication (Diphtheria & Pertussis, Influenza, Meningococcal), Pathogen Type, End-User - Global Forecast 2024-2030
... to reach USD 43.92 billion in 2024, at a CAGR 10.81% to reach USD 81.42 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Conjugate Vaccine Market. It offers ... Read More
-
Influenza Vaccine Market by Vaccine Type (Inactivated, Live Attenuated, Recombinant), Age Group (Adolescent Vaccination, Adult Vaccination, Infant Vaccination), Administration Route, Distribution Channel - Global Forecast 2024-2030
... 7.92 billion in 2023 and expected to reach USD 8.61 billion in 2024, at a CAGR 9.01% to reach USD 14.49 billion by 2030. Global Influenza Vaccine Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
South & Central America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)
... Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) The South & Central America poultry diagnostic market is expected to grow from US$ 50.52 million in 2022 to US$ 105.35 million by 2030. It ... Read More
-
Middle East & Africa Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)
... Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) The Middle East & Africa poultry diagnostic market is expected to grow from US$ 11.53 million in 2022 to US$ 22.91 million by 2030. It ... Read More
-
North America Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests and Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)
... Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) The North America poultry diagnostic market is expected to grow from US$ 118.89 million in 2022 to US$ 253.67 million by 2030. It is estimated to ... Read More
-
Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type [Enzyme-Linked Immunosorbent Assay (ELISA) Tests, Polymerase Chain Reaction (PCR) Test, Hemagglutination-Inhibition (HI), and Others] and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others)
... Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) The Europe poultry diagnostic market is expected to grow from US$ 54.50 million in 2022 to US$ 121.36 million by 2030. It is estimated to grow at a ... Read More
-
Infectious Disease Diagnostics Market based on by Product (Assays & Reagents, Instruments, and Software), Disease Type (Hepatitis, Human Immunodeficiency Virus, Influenza, and Others), and Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others),Regional Outlook– Global Forecast up to 2030
... Others),Regional Outlook– Global Forecast up to 2030 For efficient treatment and management, diseases such as TB, HIV/AIDS, hepatitis, sexually transmitted infections, and respiratory infections require an accurate and prompt diagnosis. Early detection of these disorders ... Read More
-
Global Influenza Treatment Market Size study & Forecast, by Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate, Others) by Route of Administration (Oral, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2023-2030
... 2023-2030 Global Influenza Treatment Market is valued approximately USD 5.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.18% over the forecast period 2023-2030. Influenza treatment refers ... Read More
-
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The global human ... Read More
-
Influenza Diagnostic Tests Market - By Test Type (Traditional Diagnostic Test {RIDT, DFAT, Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, LAMP, NASBAT, SAMBA}), End-use & Forecast, 2023 - 2032
... estimated to witness 6.3% CAGR between 2023 and 2032, owing to the recurrent global outbreaks of influenza that highlight the critical need for accurate and rapid diagnostic solutions. As per WHO October 2023 report, there ... Read More
-
U.S. Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture, Others), By End-use (Hospitals, POCT, Laboratories), And Segment Forecasts, 2023 - 2030
... Trends The U.S. influenza diagnostics market size is expected to reach USD 282.9 million by the year 2030 growing at a CAGR of 5.9% according to a new report by Grand View Research, Inc. Key ... Read More
-
Influenza Diagnostic Global Market Report 2024
... Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes Covering: F. ... Read More
-
Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End Use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2023 - 2030
... Trends The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, registering a CAGR of 3.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. ... Read More
-
Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 9.8 Billion by 2028, exhibiting a CAGR of 7.93% during 2022-2028. The increasing awareness about the importance of vaccination, rising prevalence of influenza, and favorable government initiatives promoting vaccination programs are some of ... Read More
-
Seasonal Influenza Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Seasonal Influenza Clinical trials scenario. This report provides top line data relating to the clinical trials on Seasonal Influenza. Report includes an ... Read More
-
Respiratory Syncytial Virus (RSV) Infections Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials scenario. This report provides top line data relating to ... Read More
-
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End user (Pediatric, Adult) & Region - Global Forecast to 2028
... The global vaccines market size is projected to reach USD 93.8 billion by 2028 from USD 77.6 billion in 2023, at a CAGR of 3.9% during the forecast period. Factors such as high incidence of ... Read More
-
Influenza Vaccines Market Report 2023-2033
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The global prevalence of influenza is on the rise. The ... Read More
-
Global Respiratory Disease Vaccine Market Size study & Forecast, by Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine) by Age Group (Pediatric, Adult), by Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Others), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030
... (Hospital & Retail Pharmacies, Government Suppliers, Others) and Regional Analysis, 2023-2030 Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of ... Read More
-
Viral Vector & Plasmid DNA Manufacturing Market by Cell Line (In-vitro, In-Vivo), Type (Adeno-Associated Virus, Adenovirus, Lentivirus), Transfection, Indication, Workflow, Application, End User - Global Forecast 2023-2030
... is projected to reach USD 7.32 billion by 2030 from USD 1.20 billion in 2022, at a CAGR of 25.30% during the forecast period. Market Segmentation & Coverage: This research report analyzes various sub-markets, forecasts ... Read More
-
Seasonal Influenza Vaccines Epidemiology Analysis and Forecast to 2032
... and B cause human disease of public health concern (WHO, 2023). Influenza transmission occurs when people with the flu cough, sneeze, or talk, thereby disseminating droplets. These droplets can land in the mouths or noses ... Read More
-
Global Influenza Vaccine Market: Analysis by Valency (Quadrivalent & Trivalent), By Vaccine Type (Inactivated And Live Attenuated), By Technology (Egg-based & Cell-based), By Age Group (Adult & Pediatric), By Route Of Administration (Injection & Nasal Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028
... Spray), By Distribution Channel (Hospitals And Pharmacy, Government And Institutions And Others), By Region Size And Trends With Impact Of COVID-19 And Forecast Up To 2028 The influenza vaccine, often referred to as the flu ... Read More
-
MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, Factor VIII ( Xyntha, Octanate, Kovaltry, Advate, Koate, Adynovate, Kogenate, Hemlibra, Elocta, Recombinate, Feiba, Immunate, Alphanate, Novoeight), Erythropoietin (Epoetin Alfa (Procrit, Epogen), Darbepoietin Alfa (Aranesp), Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt)
... Epoetin Alfa-epbx (Retacrit)), Aflibercept (EYLEA), and Ziv-Aflibercept (ZALTRAP))), By Therapeutic Application (Hemophilia, Age-related Macular Degeneration, Kidney Diseases, Influenza, and Others), By Geography (Gulf and Egypt) MENA Biologics & Biosimilars Market, By Product Type (Influenza Vaccines, ... Read More
-
Global Respiratory Syncytial Virus Diagnostic Market 2023-2030
... Antibody Method, Immunoassays and Others), and by End-Users (Hospitals, Clinics, and Laboratories), Forecast Period (2023-2030) The global respiratory syncytial virus diagnostic market is anticipated to grow at a significant CAGR of 6.5% during the forecast ... Read More
Research Assistance
